Stay updated on Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Footer revision tag changed from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T09:33:34.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page footer lists Revision: v3.5.0, replacing Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T20:12:16.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3. No study content or user-facing functionality were changed.
    Difference
    0.1%
    Check dated 2026-03-11T11:37:35.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Added site Revision: v3.4.2. Removed the government funding/operating status notice from the page.
    Difference
    0.5%
    Check dated 2026-02-11T02:18:09.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Added a government funding notice and a site revision notice (Revision: v3.4.1); removed the previous revision (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T00:25:26.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Show glossary toggle added and minor UI label changes (e.g., capitalization in 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'). The footer revision now shows v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T00:22:32.000Z thumbnail image

Stay in the know with updates to Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page.